Back
Boston Scientific Corp (BSX)
Health CareBSX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$49.86
+1.73%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$1.94
ROE
14.7%
Gross margin
68.9%
Debt/Equity
0.42x
Revenue growth
11.6%
Boston Scientific Corp — company intelligence
Earnings surprises
Q2 2026$0.86 vs $0.84 est+2.9%
Q1 2026$0.80 vs $0.79 est+0.7%
Q4 2025$0.80 vs $0.79 est+1.6%
Q3 2025$0.75 vs $0.72 est+4.1%
Analyst consensus · 38 analysts
30 Buy8 Hold0 Sell
Updated Aug 16, 2026
Insider activity · 90 days
9 buys1 sellnet +292,667 shares
Woodworth EmilyBuy 2,930 · Aug 11, 2026
Monson JonathanBuy 9,908 · Aug 10, 2026
Habiger David CBuy 2,100 · Aug 5, 2026
Recent SEC filings
4 — Insider transaction reportAug 12, 2026
4 — Insider transaction reportAug 11, 2026
4 — Insider transaction reportAug 7, 2026
Latest news
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.